Deerfield Management Adds Cara Therapeutics Inc. (CARA) To Its Equity Portfolio

James E. Flynn’s Deerfield Management, in a filing with the Securities and Exchange Commission, reported a position in Cara Therapeutics Inc. (NASDAQ:CARA).

Keep Reading →